MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy.

by Ella F Jones, Sumedha P Sinha, David C Newitt, Catherine Klifa, John Kornak, Catherine C Park, Nola M Hylton
Published 2013-01-01

Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes.

by Wei-Ching Lo, Wen Li, Ella F Jones, David C Newitt, John Kornak, Lisa J Wilmes, Laura J Esserman, Nola M Hylton
Published 2016-01-01

Evaluation of primary breast cancers using dedicated breast PET and whole-body PET

by Deep K. Hathi, Wen Li, Youngho Seo, Robert R. Flavell, John Kornak, Benjamin L. Franc, Bonnie N. Joe, Laura J. Esserman, Nola M. Hylton, Ella F. Jones
Published 2020-12-01

Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy

by Ella F. Jones, Deep K. Hathi, Rita Freimanis, Rita A. Mukhtar, A. Jo Chien, Laura J. Esserman, Laura J. van’t Veer, Bonnie N. Joe, Nola M. Hylton
Published 2020-06-01

Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection

by Alexa C. Glencer, Jasmine M. Wong, Nola M. Hylton, Gregor Krings, Emma McCune, Harriet T. Rothschild, Tristan A. Loveday, Michael D. Alvarado, Laura J. Esserman, Michael J. Campbell
Published 2021-05-01

Pubertal timing and breast density in young women: a prospective cohort study

by Lauren C. Houghton, Seungyoun Jung, Rebecca Troisi, Erin S. LeBlanc, Linda G. Snetselaar, Nola M. Hylton, Catherine Klifa, Linda Van Horn, Kenneth Paris, John A. Shepherd, Robert N. Hoover, Joanne F. Dorgan
Published 2019-11-01

Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.

by Craig J Galbán, Bing Ma, Dariya Malyarenko, Martin D Pickles, Kevin Heist, Norah L Henry, Anne F Schott, Colleen H Neal, Nola M Hylton, Alnawaz Rehemtulla, Timothy D Johnson, Charles R Meyer, Thomas L Chenevert, Lindsay W Turnbull, Brian D Ross
Published 2015-01-01

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

by Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kathy S. Albain, Erin D. Ellis, Heather Beckwith, Barbara B. Haley, Anthony D. Elias, Judy C. Boughey, Kathleen Kemmer, Rachel L. Yung, Paula R. Pohlmann, Debu Tripathy, Amy S. Clark, Hyo S. Han, Rita Nanda, Qamar J. Khan, Kristen K. Edmiston, Emanuel F. Petricoin, Erica Stringer-Reasor, Carla I. Falkson, Melanie Majure, Rita A. Mukhtar, Teresa L. Helsten, Stacy L. Moulder, Patricia A. Robinson, Julia D. Wulfkuhle, Lamorna Brown-Swigart, Meredith Buxton, Julia L. Clennell, Melissa Paoloni, Ashish Sanil, Scott Berry, Smita M. Asare, Amy Wilson, Gillian L. Hirst, Ruby Singhrao, Adam L. Asare, Jeffrey B. Matthews, Nola M. Hylton, Angela DeMichele, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, W. Fraser Symmans, Laura J. van‘t Veer, Donald A. Berry, Laura J. Esserman
Published 2021-10-01